Two West Coast companies – Pascal Biosciences and SoRSE Technology – are collaborating to move the cannabinoid PAS-393 into clinical trials to test the drug’s effectiveness on a common immune-evading strategy that many metastatic cancers employ. Pascal, which is headquartered in Vancouver, has discovered that its PAS-393 has the potential to make tumor cells susceptible […]
Clinical trials will test cannabis-based cancer therapy is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Be First to Comment